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Editorial on the Research Topic
Muscle-Tendon-Innervation Unit: Degeneration and Aging—Pathophysiological and
Regeneration Mechanisms
This research topic brings together basic researchers and clinicians working in the area of
neuroscience, aging, sarcopenia, and orthopedics in human and in animal models with the aim
to accelerate our understanding of the mechanisms involved in aging and degeneration of the
muscle-tendon unit and its innervation and to explore the therapeutic potential of different
interventions.
Tendon injuries are the most common cause of chronic pain and temporary/permanent
disability in both the world of sport and at work. Tendinopathy, once mostly associated with
inflammation and called tendonitis, is now considered the result from an imbalance between
protective/regenerative modifications and acute or chronic tendon overload. The treatment
modalities of tendinopathy are very different and even conflicting and have in common a lack
of scientific evidence. It is therefore important to investigate the basic mechanisms that have
translational purposes.
Chen et al. observed in the skeletal muscle of rabbits fed a 2% cholesterol-enriched diet
for 12 weeks the presence of abnormally enlarged endolysosomes containing accumulations of
free cholesterol and multiple Alzheimer’s disease (AD) marker proteins subject to misfolding
and aggregation including Aβ, phosphorylated tau, and ubiquitin. These results suggest that
elevated levels of plasma cholesterol can alter endolysosome structure and function promoting the
development of AD-like pathological features in skeletal muscle, which might contribute to the
development of skeletal muscle dysfunction in AD patients (Chen et al.).
Schulz-Schaeffer is proposing that camptocormia in Parkinson’s disease (PD), a situation
characterized by an anterior flexion of the spine, is related to proprioceptive dysregulation.
Camptocormia occurs in several conditions including myopathies, myositis, dystonia, and is
particularly frequent in PD. Besides central proprioceptive dysregulation of muscle tone like
in PD-associated camptocormia, similar myopathological changes can be observed whether the
alterations of the proprioceptive polysynaptic reflex arch occur at the level of the Golgi tendon
organ, the dorsal root ganglia, or nerves by disk herniation or aging spondylotic changes
(Schulz-Schaeffer).
Vasta et al. reviewed the biological processes involved in tendon healing including the synthesis
of collagen and focusing in particular on the role of vascular and neuronal molecular pathways.
Vascular endothelial growth factor (VEGF) has shown a key angiofibroblastic role in tendon healing
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both in animal models and in vivo in patients. Recent studies have
enlightened the positive role of neurotransmitters like substance
P and nitric oxide in the treatment of tendinopathy, supporting
the hypothesis of a nerve-mediated dysregulation of tendon
metabolism (Vasta et al.).
Yin et al. report that semaphorin 3A is a potent inhibitor of
axonal outgrowth and vascular proliferation and has a negative
regulation of the matrix metalloproteinases, which are involved
in degradation of extracellular matrix proteins of disk. This
suggests that semaphorin 3A may act as a potential target for low
back pain (Yin et al.).
Rosso et al. reviewed the role of mechanical stimulation
by means of extracorporeal shock wave (ESW) and pulsed
electromagnetic fields (PEMF) for the treatment of tendinopathy
and tendon regeneration. While preclinical and in vitro studies
suggested effectiveness, the authors pointed out that there is still
a lack of strong evidence of the efficacy of these modalities in
the clinical settings, suggesting the need of further in vivo human
studies to confirm the clinical efficacy of mechanical stimulation
for the treatment of tendinopathies (Rosso et al.).
Parchi et al. reviewed the various applications of nanoparticles
for tendon healing and regeneration: labeling tendon stem cells,
acting as carrier for gene therapy and drug delivery, allowing
the construction of a new generation of bioactive scaffolds, and
modulating the cellular and extracellular matrix response. In
their paper, the authors highlighted and summarized the most
recent advances and results (Parchi et al.).
Frizziero et al. reviewed the most recent clinical and
experimental studies regarding the consequences of detraining
in tendon mechanobiology. Overall, the in vitro and in vivo
models showed, after detraining, noticeable alterations of tissue
structural organization and of mechanical properties. Although
clinical studies showed more variable results, the authors
suggest that after a period of sudden detraining physical
activity including rehabilitation should be restarted with caution
(Frizziero et al.).
Giusti and Pepe described the organization of elastic fibers
in tendon and particularly of fibrillin 1 and fibrillin 2 in
some animal models and in humans. They review the clinical
manifestations of monogenic disorders due to mutations in the
genes of fibrillin 1 (Marfan syndrome) and fibrillin 2 (Congenital
contractural arachnodactyly), which may cause a combination of
joint hypermobility and contractures (Giusti and Pepe).
Popov et al. studied the aged related phenotype of tendon
stem/progenitor cells (TSPCs) and its effect on tendon
maintenance and healing. Their results showed a significant
down regulation of the ephrin receptors EphA4, EphB2,
and EphB4 and ligand EFNB1 in aged TCPC. These novel
data suggest that decreased expression of ephrin receptors
during tendon aging and degeneration limits the establishment
of appropriate cell–cell interactions between TSPC and
significantly diminishes their proliferation, motility and actin
turnover (Popov et al.).
Raz et al. investigated age-associated changes in shoulder
muscle pathology combining radiological and histological
procedures. They found that patterns of age-associated muscle
degeneration were similar between individuals with and without
muscle tears. Furthermore, they found that torn rotator cuff
muscles display tissue hallmarks of muscle aging, including
fatty infiltration, increase in extra-cellular matrix, and loss of
slow oxidative myofibers. In contrast, the teres minor exhibited
healthy muscle features suggesting that teres minor could
represent an aging-resilient muscle (Raz et al.).
Salini et al. compared the efficacy of platelet rich plasma
(PRP) therapy in young and elderly subjects suffering for Achilles
tendinopathy. They found that PRP is less effective in aged
people, suggesting that this can be ascribed to several biochemical
and biomechanical differences documented in tendons of young
and elderly subjects with the latter showing reduced number and
functionality of tenocytes and tenoblasts, which become more
evident in the long-term tissue healing (Salini et al.).
Sardone et al. studied a peroneal tendon biopsy and tenocyte
culture of a patient with Ullrich congenital muscular dystrophy
(UCMD) due to compound heterozygous mutations in the
COL6A2 gene. They found irregular profile and reduced mean
diameter of tendon fibrils, and abnormal accumulation of
collagen VI and altered distribution of collagen I and fibronectin.
In tenocyte culture, collagen VI web formation and cell surface
association were severely impaired and metalloproteinase MMP-
2 was increased in the conditioned medium. Altogether, these
new data indicate that collagen VI deficiency may influence the
organization of UCMD tendon matrix, resulting in dysfunctional
fibrillogenesis (Sardone et al.).
Finally, we realize that this collection of articles and
reviews cannot exhaust all lines of research related to the
biology and the pathology of the muscle-tendon complex
and its innervation. These articles, however, outline the main
pathogenetic mechanisms and thus the possible rehabilitation
therapeutic interventions to counteract the aging process of
the nerve-muscle-tendon unit. We hope that the items of this
collection will be a stimulus for future progress toward a niche
of research with great expectations for aging well.
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